BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34856776)

  • 1. Assessment of Utilization of Post Exposure Prophylaxis (PEP) among HIV-Exposed Individuals in a Tertiary Hospital, Northwest Nigeria.
    Ogunsina MA; Yusuf-Ajibade N; Maaji E; Shuiabu M
    West Afr J Med; 2021 Oct; Vol. 38(10):999-1003. PubMed ID: 34856776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infections averted at PEPFAR-APIN clinics in Nigeria: a ten-year retrospective evaluation of the clinical outcomes of post-exposure prophylaxis services.
    Isah A; Igboeli NU; Dim OF; Ekwuofu AA
    Afr J AIDS Res; 2023 Apr; 22(1):46-53. PubMed ID: 36951407
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.
    Tetteh RA; Nartey ET; Lartey M; Mantel-Teeuwisse AK; Leufkens HG; Nortey PA; Dodoo AN
    BMC Public Health; 2015 Jun; 15():573. PubMed ID: 26092496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Postexposure Prophylaxis (PEP) in a Nigerian Tertiary Health Institution.
    Onyedum CC; Chukwuka C; Iyoke CA; Omotola OF
    J Int Assoc Physicians AIDS Care (Chic); 2011; 10(3):171-5. PubMed ID: 21368009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus postexposure prophylaxis at IBadan, Nigeria.
    Olowookere SA; Fatiregun AA
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(3):187-90. PubMed ID: 20357035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of knowledge, attitude and practice of post exposure prophylaxis for HIV among nurses at Jigme Dorji Wanghuck National Referral Hospital, Bhutan.
    Tshering K; Wangchuk K; Letho Z
    PLoS One; 2020; 15(8):e0238069. PubMed ID: 32857804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.
    Young TN; Arens FJ; Kennedy GE; Laurie JW; Rutherford Gw
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002835. PubMed ID: 17253483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and practice of post-exposure prophylaxis (PEP) against HIV infection among health care providers in a tertiary hospital in Nigeria.
    Owolabi RS; Alabi P; Ajayi S; Daniel O; Ogundiran A; Akande TM; Onafowokan AT
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(3):179-83. PubMed ID: 21511981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, Attitude and Practice of HIV Post-Exposure Prophylaxis among Medical Doctors in a Tertiary Hospital in Nigeria.
    Umoh VA; Jombo HE; Ekpo O; Amanari CO
    West Afr J Med; 2020; 37(1):19-25. PubMed ID: 32030707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge of human immunodeficiency virus post-exposure prophylaxis among doctors in a Nigerian tertiary hospital.
    Esin IA; Alabi S; Ojo E; Ajape AA
    Niger J Clin Pract; 2011; 14(4):464-6. PubMed ID: 22248951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India.
    Gupta A; Anand S; Sastry J; Krisagar A; Basavaraj A; Bhat SM; Gupte N; Bollinger RC; Kakrani AL
    BMC Infect Dis; 2008 Oct; 8():142. PubMed ID: 18939992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational post-exposure prophylaxis (PEP) against human immunodeficiency virus (HIV) infection in a health district in Cameroon: assessment of the knowledge and practices of nurses.
    Aminde LN; Takah NF; Dzudie A; Bonko NM; Awungafac G; Teno D; Mbuagbaw L; Sliwa K
    PLoS One; 2015; 10(4):e0124416. PubMed ID: 25879442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
    Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
    Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of occupational injuries and knowledge of availability and utilization of post exposure prophylaxis among health care workers in Singida District Council, Singida Region, Tanzania.
    Kimaro L; Adinan J; Damian DJ; Njau B
    PLoS One; 2018; 13(10):e0201695. PubMed ID: 30359370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
    Beekmann SE; Henderson DK
    Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post exposure prophylaxis following occupational exposure to HIV: a survey of health care workers in Mbeya, Tanzania, 2009-2010.
    Mponela MJ; Oleribe OO; Abade A; Kwesigabo G
    Pan Afr Med J; 2015; 21():32. PubMed ID: 26405468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV Non-Occupational Post Exposure Prophylaxis in Nigeria: A Systematic Review of Research Evidence and Practice.
    Iloanusi SH; Mgbere OO; Abughosh SM; Essien EJ
    Int J MCH AIDS; 2019; 8(2):101-119. PubMed ID: 31803532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.